AZD9291 First Time In Patients Ascending Dose Study

Clinical trial NCT01802632 · COMPLETED

Trial details

NCT number: NCT01802632
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Non Small Cell Lung Cancer Advanced (Inoperable) Non Small Cell Lung Cancer

Start date: 2013-03-04
Primary completion: 2015-05-01
Enrollment: 603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.